Catalist: A platform for growth firms or ICU for mainboard patients?
The less stringent listing rules on SGX’s second board adversely affect investor protection and the quality of the issuers, which could in turn harm its reputation.
Read MorePosted by Mak Yuen Teen | Jan 16, 2019 | Articles
The less stringent listing rules on SGX’s second board adversely affect investor protection and the quality of the issuers, which could in turn harm its reputation.
Read MorePosted by Mak Yuen Teen | Jan 15, 2019 | Articles
If a company cannot turn itself around after 36 months (plus possibly more time since SGX does grant extensions), is allowing them to transfer to Catalist the answer?
Read MorePosted by Mak Yuen Teen | Dec 21, 2018 | Articles
Posted by Mak Yuen Teen | Dec 13, 2018 | Articles
Perhaps SGX would be as curious as I am about whether the reasons stated are accurate?
Read MorePosted by Mak Yuen Teen | Dec 13, 2018 | Articles
More discussion about investor protection and minority shareholder rights is needed.
Read More